Why do patients die after myocardial infarction?

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Clinical Research

Background:

• Myocardial infarction (MI) can lead to death through various mechanisms.
• Early mortality causes like ventricular fibrillation and cardiac rupture may not correlate with infarct size.
• Later mortality is often linked to infarct size, extension, and expansion, involving heart failure, shock, and arrhythmias.

Purpose of the Study:

• To review the causes of death during and after myocardial infarction.
• To explore the relationship between infarct size and mortality.
• To discuss preventive strategies targeting different mortality mechanisms.

Main Methods:

• Literature review and synthesis of existing research on myocardial infarction mortality.
• Analysis of mechanisms contributing to early and late deaths post-MI.
• Evaluation of the roles of various pharmacological interventions.

Main Results:

• Early deaths (e.g., ventricular fibrillation, cardiac rupture) may be independent of infarct size.
• Later deaths are associated with infarct size, infarct extension/expansion, leading to cardiac failure, shock, and arrhythmias.
• Pharmacological agents demonstrate varied preventive effects.

Conclusions:

• Preventive strategies must address specific mortality mechanisms.
• Thrombolytic drugs limit infarct size, reducing multiple causes of death.
• Beta-blockers prevent early rupture, reinfarction, and late ventricular fibrillation.
• Aspirin is effective in preventing reinfarction.
• Angiotensin-converting enzyme (ACE) inhibitors may aid early cardiac unloading and later prevent infarct expansion and heart failure.